Headline News

The American College of Rheumatology has joined a coalition of more than 40 other organizations calling on congressional leaders to address what they see as insufficient Medicare reimbursements for biosimilars.

The Advanced Research Projects Agency for Health announced funding worth up to $125 million to help four teams research eye transplantation, according to a press release.

NEW YORK — In this Healio Video Perspective from OSN New York, George O. Waring IV, MD, FACS, discusses the benefits of the EVO ICL from STAAR Surgical.

Higher intake of dietary niacin decreased the risk for all-cause mortality and cardiovascular -related death, according to results of a retrospective cohort study published in Scientific Reports.

Topline results from a phase 1 extension study show EO2002, a nonsurgical cell therapy for corneal edema, improved best corrected visual acuity at 6 months and maintained a strong safety profile, according to a press release from Emmecell.

Timolol microdrops administered with the Nanodropper Adaptor were as effective as conventional drops at lowering IOP among patients with open-angle glaucoma and ocular hypertension, according to a study published in Ophthalmology.

DALLAS — Results presented here showed standard liners and constrained liners had similar rates of aseptic failure and dislocation among patients undergoing revision total hip arthroplasty with a custom triflange acetabular component.

A novel device using radiofrequency and high-intensity facial electrical stimulation could mitigate the risk for facial muscle atrophy following repeated botulinum toxin injections, according to a study.

Sexual and gender minority physicians and trainees had a higher likelihood for burnout and lack of professional fulfillment compared with their straight, cisgender colleagues, according to study results published in JAMA Network Open.

Topline results from the phase 3 ReThink-ALZ study of simufilam in mild to moderate Alzheimer’s disease showed the investigational therapeutic did not meet any of its prespecified endpoints.